Biogen Inc.
$187.06
$2.22(-1.17%)
Biogen Inc.
BIIB
$187.06
$2.22(-1.17%)
Biogen Inc.
BIIB
NASDAQ
$187.06
$2.22(-1.17%)
Chart
Upcoming Earnings
Next report date
Jul 30, 2026
Report period
Q3 2026
EPS Estimate
$3.33
Revenue Estimate
$2.43B
Key stats
52-Week Range$187.06
$110.04
$176.00
Market capitalization
$25.72BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
20.06Basic EPS (TTM)
$8.85Net income (TTM)
$1.29BRevenue (TTM)
$9.81BAvg. volume
1.72MBeta (1Y)
0.16Employees
7.61KMarket capitalization
$25.72BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
20.06Basic EPS (TTM)
$8.85Net income (TTM)
$1.29BRevenue (TTM)
$9.81BAvg. volume
1.72MBeta (1Y)
0.16Employees
7.61KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Biogen Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher A. Viehbacher
Website
www.biogen.comHeadquarters
225 Binney Street, Cambridge, MA, 02142
IPO Date
1991-09-17
Identifiers
ISIN
US09062X1037Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company...
Related Stocks
$35.86
1D:
1.4%
1Y:
118.8%
US8816242098Healthcare
Mkt Cap
$41.76B
P/E Ratio TTM
25.7
Revenue TTM
$17.26B
Beta
0.86
Earnings TTM
$1.41B
Dividend Yield TTM
0.00%
$572.20
1D:
-1.6%
1Y:
91.6%
US91307C1027Healthcare
Mkt Cap
$25.08B
P/E Ratio TTM
18.9
Revenue TTM
$3.18B
Beta
0.75
Earnings TTM
$1.33B
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate